SASTASUNDR2023-04-012023-06-30 SASTASUNDR2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member SASTASUNDR2023-06-30 SASTASUNDR2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 533259 SASTASUNDR NOTLISTED Sastasundar Ventures Limited Equity 2023-04-01 2024-03-31 2023-08-11 2023-08-01 INR Lakhs First quarter 2023-08-11 15:00:00 2023-08-11 16:30:00 false Not applicable Single segment Financial Services 2023-04-01 2023-06-30 Unaudited Standalone 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2860000.00 2860000.00 0.00 0.00 0.00 1082000.00 39000.00 259000.00 0.00 0.00 0.00 0.00 5193000.00 6573000.00 -3713000.00 0.00 -3713000.00 0.00 0.00 0.00 -3713000.00 0.00 0.00 0.00 0.00 -3713000.00 -111000.00 -3824000.00 -3824000.00 0.00 318105000.00 10 -0.12 -0.12 0.00 0.00 -0.12 -0.12 0.00 0.00 0.00 1. The above Unaudited Financial Results for the quarter ended June 30, 2023 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on August 11, 2023. The Limited review for the quarter ended June 30, 2023 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LODR) Regulation, 2015. 2. The Company being a Core Investment Company has only one reportable business segment and operates in only one geographical segment i.e. within India. 3. The Reserve Bank of India vide its press release dated 30th September, 2022 has categorised Sastasundar Venture Limited ('SVL'), in the Middle layer under Scale Based Regulation (SBR) for NBFC's. The Company is taking necessary steps in complying with the requirements of SBR as applicable. 4. During the previous year, the Board of Directors at its meeting held on 27th March, 2023 approved a Composite Scheme of Arrangement (the Scheme) for Demerger and Amalgamation amongst Sastasundar Ventures Limited (‘Demerged Company’ or ‘Amalgamated Company’) and Microsec Resources Private Limited (“Resulting Company”) and Sastasundar Healthbuddy Limited (“Amalgamating Company”) under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013 and the rules made there under, with effect from 1st April, 2023 (the Appointed Date). The Scheme is subject to requisite approvals of the concerned regulatory authorities. Pending such approvals, the scheme has not been recognised in these financial results. In the current quarter, Other expenses includes expenses of Rs. 30.11 lakhs in relation to Composite Scheme of Arrangement (the Scheme) for Demerger and Amalgamation. 5. During the previous year, the Company has sold its properties for Rs. 211.50 Lakhs and Profit amounting to Rs. 126.11 Lakhs had been recognised as other income in previous year results . 6. The figure for the quarter ended 31st March, 2023 are the balancing figure between audited figure in respect of the full financial year and the unaudited published period to date reviewed figures upto the end of the third quarter 31st December, 2022 which were subjected to a limited review. 7. Previous Year/ Period figures have been re-grouped / re-classified wherever necessary. Other Expenses 5193000.00 0.00 0.00 0.00 0.00 Remeasurement gain/loss on defined benefit plans (net of tax) -111000.00 -111000.00 0.00 0.00 -111000.00